Less Ads, More Data, More Tools Register for FREE

Pin to quick picks3i Group Regulatory News (III)

Share Price Information for 3i Group (III)

Share Price is delayed by 15 minutes
Get Live Data
2,209.00    19.00 (0.87%)
Bid:
2,212.00
Ask:
2,214.00
Spread: 2.00 (0.09%)
Market Cap: £22.41b
III Live PriceLast checked at - London Stock Exchange

Intraday 3i Group Share Chart

Interim Management Statement

26 Jan 2012 07:00

RNS Number : 1951W
3i Group PLC
26 January 2012
 



26 January 2012

 

 

 

3i Group plc - Interim Management Statement

 

 

3i Group plc ("3i"), the international private equity firm, today issues its Interim Management Statement in accordance with FSA Disclosure and Transparency Rule 4.3. This statement which, as usual, is unaudited, relates to the three month period from 30 September 2011 to 31 December 2011.

 

Michael Queen, 3i's Chief Executive, said: "We have made a number of important strategic steps to strengthen each of our business lines in the period, including the reorganisation of our private equity business, signing our first investment in Brazil, and the launch of our Credit Opportunities Fund."

 

"We have also generated good realisations from the portfolio, although, as we said in our November half-year results announcement, the operating environment is challenging given the deterioration in the macro-economic outlook and continued market uncertainty. Conditions have not improved since then, which has been reflected in a softening in the earnings performance of some of the portfolio over this period."

 

 

1. Investment

Investment by business line was as follows:

 

Investment (£m)

 

Six months ended

Three months ended

Nine months to

Nine months to

30 September

31 December

31 December

31 December

2011

2011

2011 (total)

2010 (total)

Private Equity

Buyouts

292

65

357

436

Growth Capital

117

4

121

23

Infrastructure

33

-

33

15

Debt Management

6

13

19

36

Total

448

82

530

510

 

 

2. Realisations

 

Realisations by business line were as follows:

Realisations (£m)

 

Six months ended

Three months ended

Nine months to

Nine months to

30 September

31 December

31 December

31 December

2011

2011

2011 (total)

2010 (total)

Private Equity

Buyouts

360

202

562

168

Growth Capital

163

16

179

126

Infrastructure

1

-

1

1

Debt Management

-

-

-

40

Non-core

8

1

9

63

Total

532

219

751

398

 

 

3. Cashflow and balance sheet

 

The Group had cash, cash deposits and undrawn committed facilities of £1,753 million as at 31 December 2011 (30 September 2011: £1,680 million) and gross debt had reduced to £1,659 million (30 September 2011: £1,722 million).

 

Net cash divestment in the three month period was £159 million and net debt decreased by £136 million to £395 million (30 September 2011: £531 million).

 

 

 

Ends

 

For information please contact:

 

Patrick Dunne

Group Communications Director, 3i Group plc

020 7975 3566

 

Kathryn van der Kroft

PR Director

020 7975 3021

 

 

 

 

This statement aims to give an indication of material events and transactions that have taken place during the period from 30 September 2011 to 31 December 2011 and their impact on the financial position of 3i Group plc. These indications reflect the Board's current view. They are subject to a number of risks and uncertainties and could change. Factors which could cause or contribute to such differences include, but are not limited to, general economic and market conditions and specific factors affecting the financial prospects or performance of individual investments within 3i's portfolio.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBAMRTMBJTBLT
Date   Source Headline
5th Jun 20264:00 pmRNSHolding(s) in Company
2nd Jun 20264:24 pmRNSDirector/PDMR Shareholding
2nd Jun 20263:37 pmRNSDirector/PDMR Shareholding - Amendment
1st Jun 20264:28 pmRNSDirector/PDMR Shareholding
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 20265:42 pmRNSTotal Voting Rights
29th May 20265:38 pmRNSAdmission to Trading
27th May 202610:42 amRNSNotice of AGM
26th May 20267:00 amRNSTransaction in Own Shares
22nd May 202612:29 pmRNSDirector/PDMR Shareholding
21st May 20267:40 amRNSDoc re. 2026 Annual Report and Accounts
19th May 20262:28 pmRNSDirector/PDMR Shareholding
18th May 20267:00 amRNSTransaction in Own Shares
15th May 202610:24 amRNSDirector/PDMR Shareholding
14th May 202610:41 amRNSHolding(s) in Company
14th May 20267:02 amRNSCommencement of Share Buyback Programme
14th May 20267:00 amRNSResults for the year to 31 March 2026
1st May 202612:00 pmRNSDirector/PDMR Shareholding
30th Apr 20263:34 pmRNSTotal Voting Rights
30th Apr 20263:31 pmRNSAdmission to Trading
7th Apr 202612:33 pmRNSHolding(s) in Company
1st Apr 20269:53 amRNSPortfolio Update
1st Apr 20269:36 amRNSDirector/PDMR Shareholding
31st Mar 20262:30 pmRNSTotal Voting Rights
31st Mar 20262:29 pmRNSAdmission to Trading
31st Mar 202611:37 amRNSDirector/PDMR Shareholding
30th Mar 20267:00 amRNSDirector/PDMR Shareholding
27th Mar 20263:07 pmRNSAdmission to Trading
26th Mar 20267:00 amRNSAction Capital Markets Seminar & portfolio update
23rd Mar 202612:11 pmRNSHolding(s) in Company
2nd Mar 202612:18 pmRNSDirector/PDMR Shareholding
27th Feb 20264:00 pmRNSTotal Voting Rights
3rd Feb 202610:20 amRNSHolding(s) in Company
3rd Feb 202610:17 amRNSDirector Declaration
30th Jan 20262:24 pmRNSDirector/PDMR Shareholding
30th Jan 20261:47 pmRNSTotal Voting Rights
29th Jan 202612:19 pmRNSDirector/PDMR Shareholding
29th Jan 20267:00 amRNSFY2026 Q3 performance update
7th Jan 20262:06 pmRNSDirector/PDMR Shareholding
6th Jan 20261:53 pmRNSTotal Voting Rights
2nd Jan 202611:06 amRNSPortfolio Update
9th Dec 20251:11 pmRNSBlock listing Interim Review
4th Dec 20252:12 pmRNSDirector/PDMR Shareholding
1st Dec 20251:25 pmRNSDirector/PDMR Shareholding
28th Nov 20254:24 pmRNSTotal Voting Rights
20th Nov 20259:59 amRNSDirector/PDMR Shareholding
18th Nov 20252:23 pmRNSDirector/PDMR Shareholding
17th Nov 202512:50 pmRNSDirector/PDMR Shareholding
17th Nov 202512:48 pmRNSDirector/PDMR Shareholding
14th Nov 20254:20 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.